Skip to main content
50°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
4.560
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Agenus Inc
< Previous
1
2
3
4
5
Next >
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
September 18, 2024
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The...
Via
Benzinga
Exposures
Product Safety
Agenus (AGEN) Q2 2024 Earnings Call Transcript
August 08, 2024
AGEN earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
AGEN stock results show that Agenus missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Agenus reports that Bristol Myers Squibb (NYSE: BMY) is ending their 2021 agreement, returning the TIGIT bispecific antibody AGEN1777. This decision is part of Bristol Myers' broader pipeline strategy...
Via
Benzinga
Agenus Faces Regulatory and Financial Challenges: Analyst Downgrades Stock Pending Trial Clarity
July 19, 2024
Agenus faces a setback as the FDA advises against accelerated approval for its immunotherapy combination, botensilimab and balstilimab, for relapsed/refractory microsatellite-stable colorectal cancer....
Via
Benzinga
Exposures
Product Safety
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
April 28, 2024
This small-cap biotech stock is surging. Time to buy?
Via
The Motley Fool
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
July 18, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
Via
Benzinga
Dow Dips 250 Points; US Weekly Jobless Claims Surge
July 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
WBD Stock Pops as Warner Bros. Considers Streaming Spinoff
July 18, 2024
Warner Bros. stock is rising on Thursday as reports about a potential spinoff of its streaming division embolden WBD investors.
Via
InvestorPlace
Agenus Loses More Than 50% Value On Thursday - Here's Why
July 18, 2024
Agenus shares drop amid FDA's feedback on its immunotherapy combo botensilimab and balstilimab for colorectal cancer. The FDA advised against accelerated approval, citing concerns about survival...
Via
Benzinga
Exposures
Product Safety
Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
July 18, 2024
NKGen Biotech stock is up Thursday as NKGN holders react to plans for a presentation at the Alzheimer’s Association International Conference.
Via
InvestorPlace
Why Is Agenus (AGEN) Stock Down 55% Today?
July 18, 2024
Agenus stock is down on Thursday after the company provided AGEN investors with an update on a Phase 2 clinical trial meeting.
Via
InvestorPlace
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
July 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
May 30, 2024
Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended.
Via
InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.
Via
InvestorPlace
3 Magnificent Growth Stocks to Buy Hand Over Fist
May 22, 2024
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
Agenus (AGEN) Q1 2024 Earnings Call Transcript
May 07, 2024
AGEN earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AGEN Stock Earnings: Agenus Misses EPS, Misses Revenue for Q1 2024
May 07, 2024
AGEN stock results show that Agenus missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month
April 23, 2024
Via
Benzinga
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Via
Benzinga
Small-Cap Cancer Drug Developer Agenus' Highlights Encouraging Data From Colorectal Cancer, But Funding Concerns Loom
April 12, 2024
The latest Phase 1 trial results of Agenus' botensilimab and balstilimab (BOT/BAL) combination therapy for metastatic CRC showcase promising clinical activity.
Via
Benzinga
Gold Moves Higher; Auddia Shares Surge
April 08, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded up 0.04% to 38,919.32 while the NASDAQ rose 0.11% to 16,266.07. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 08, 2024
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 08, 2024
Via
Benzinga
Crude Oil Moves Lower; Perion Network Shares Tumble
April 08, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.